Key result
An optimized, rapid chromogenic assay provides a specific method for measuring direct factor Xa inhibitors, such as rivaroxaban, in plasma.
Describes an optimized, rapid chromogenic assay for measuring rivaroxaban in plasma.
May aid rivaroxaban monitoring in select settings; leaves open prospective clinical validation before routine use.
No takes yet. Share an insight, caveat, or question.
Amiral et al. (2010) studied this question. An optimized, rapid chromogenic assay provides a specific method for measuring direct factor Xa inhibitors, such as rivaroxaban, in plasma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: